Author Affiliation: Departments of Psychiatry and Neuroscience, Harvard Medical School, Boston, Mass.
The study by Zito and colleagues1 in
this issue of THE JOURNAL on the use of psychotropic medications in very young
children in 2 Medicaid programs and a managed care organization suggests that
1% to 1.5% of all children 2 to 4 years old enrolled in these programs currently
are receiving stimulants, antidepressants, or antipsychotic medications. The
authors also report that the prevalence of neuropsychopharmacologic interventions
in this age group increased substantially during the last decade.
Coyle JT. Psychotropic Drug Use in Very Young Children. JAMA. 2000;283(8):1059-1060. doi:10.1001/jama.283.8.1059